semaglutide eye blindness damage A new study suggests patients taking — the active ingredient in Ozempic and Wegovy — may be at higher risk of developing an The popularity of GLP-1 agonists

Understanding how these peptides work together advances knowledge that may inform the next generation of healing therapies

If side effects make eating difficult, adjust your food choices and meal timing rather than skipping meals altogether

Purpose-built for physicians For older adults with diabetes, CV risk lower with SGLT2 or GLP-1 vs

Read more: #RareDisease #Oclaiz #NewDrugApplication #Camurus To view or add a comment, sign in The Food and Drug Administration approves the request to designate the Cevince drug within the orphan drug registration process The Saudi Food and Drug Authority approved the company's application PTC Therapeutics To designate Cevince (Sepiapterin) under the orphan drug registration pathway, for use in treating high levels of the amino acid phenylalanine in the blood

They don't create energy, but force your body to burn through existing reserves faster

This is a compound where the preclinical signal is strong, but the clinical confirmation is incomplete